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Graphical Abstract 
 
  
ABSTRACT: In the absence of a steric directing group iridium-catalyzed C-H borylation of N-protected indazoles 
occurs rapidly and selectively at C-3 and the resulting boronate esters can be utilized in a range of downstream 
conversions. The functional group tolerance of the iridium-catalyzed C-H borylation reaction enables simple and 
efficient multidirectional syntheses of substituted indazoles to be realized. 
 
Organoboronic acids and esters are of great importance in organic, medicinal and material chemistry.
1 
Reflect-
ing this, methods for the preparation of functionalized boronic acids and their derivatives are of great interest. Alt-
hough classically prepared via transmetallation and trapping with boron electrophiles, recent developments in 
boronate ester synthesis have focused on milder more functional group tolerant approaches. Foremost among 
these are metal catalyzed C-X and C-H borylation.
2-5
 Of these, the direct C-H borylation of aromatic C-H bonds 
catalyzed by boryl iridium complexes is particularly attractive as it enables late stage functionalization of mole-
cules. However, many important basic heterocycles are not well tolerated, giving slow reactions with low conver-
sions.
6
 These characteristics can be related to the ability for the basic nitrogen to coordinate to, and thus inhibit, 
the Ir-catalyst and the related presence of the proximal azinyl nitrogen lone pair which provides an inhibitory re-
pulsive interaction with the developing negative charge of the ortho carbon during the C-H activation step, and 
also a low energy pathway for protodeboronation.
7,8
 We have recently demonstrated that the introduction of a 
strongly electron withdrawing group at the 2-position of a pyridine lowers the basicity of the azinyl nitrogen (pKa 
pyridine  5.25, 2-chloropyridine 0.7, 2-fluoropyridine -0.44), facilitating borylation at the 6-position and providing 
  
2 
the resulting boronate ester with much enhanced stability (Figure 1).
7
 Other substituents can have a similar effect, 
with the presence of a second azinyl nitrogen atom also leading to lower pKa values and enhanced reactivity in 
the C-H borylation process (Figure 2). We then considered azole systems and noted that Harrity has previously 
demonstrated that 3-pyrazole boronate esters, in which there is a nitrogen atom adjacent to the azine moiety, are 
stable entities.
9
 In addition, Smith and Malezcka have shown that protected pyrazoles are viable substrates for 
borylation and, in these cases, reaction occurs exclusively at C-4, remote from the azinyl nitrogen.
6e 
Consequent-
ly, reflecting their importance in a variety of medicinal chemistry applications, we became interested in the reactiv-
ity and selectivity of indazole borylation in which the NR group adjacent to the azinyl nitrogen reduces the basicity 
of the nitrogen atom (pKa indazole 1.25 cf. 2-methoxypyridine 3.3 and 2-chloropyridine 0.7). Prompted by a recent 
disclosure from a group at Syngenta,
10
 we now describe the development of simple, multi-directional syntheses of 
indazoles based on selective C-H borylation of this heterocycle. 
Figure 1. C-H Borylation of 2-Fluoropyridines 
 
Figure 2. pKa values for azinyl ring systems
11
 
 
Our initial experiments explored the borylation of the parent indazole. Consistent with attempts to borylate other 
heterocycles which contain an unencumbered azinyl nitrogen, no reaction was observed. Smith and Maleczka 
have recently shown that the N-H group of various heterocycles can be temporarily protected by N-H borylation 
with HBpin.
12
 However, we were not able to achieve the borylation of indazole following this protocol. Conse-
quently a series of different, less labile, nitrogen protecting groups were explored (Table 1). Borylation of 1-
protected indazole with one equivalent of B2pin2 afforded the 3-borylated product, as confirmed by a distinct shift 
of the 4-H resonance to higher frequency in the 
1
H NMR spectrum. Significantly, and consistent with our previous 
  
3 
results, more strongly electron-withdrawing protecting groups led to faster reactions and higher conversions. 
Somewhat surprisingly, borylation of the corresponding N2-protected indazoles also proceeds exclusively 
Table 1  Borylation of N-protected indazoles 
   
at the 3-position even in the presence of relatively bulky benzyl or THP protecting groups at N-2 (Table 1, en-
tries 8-11). The higher reactivity of these isomers was most notably seen with complete borylation of the bulky 
3,5-dimethylbenzyl derivative being observed in minutes in contrast to the many hours required for the analogous 
1-N protected isomer. We attribute this higher reactivity of the 2-protected isomers to the fact that the site of C-H 
activation is no longer adjacent to an azinyl lone pair. This also mirrors the more rapid reaction of a pyrrole when 
compared with a 2-substituted pyridine and the preference for C-H borylation in a pyrazole to occur at C-4, not C-
3. Most of these -azinyl boronate esters, although considerably more stable than simple 2-pyridyl boronates, 
proved to be prone to protodeboronation, and attempts to purify them using column chromatography were com-
plicated by partial reversion to the starting indazole. The incorporation of a more electron deficient sulfonyl group 
(Table 1 entry 7) overcame this challenge and these boronate esters were amenable to standard chromatograph-
ic purification. Reflecting this decomposition pathway, for all other substrates, following characterization of the 
crude borylation reaction mixture by a combination of NMR spectroscopy and GCMS, each indazole boronate 
ester was subjected to a standard Suzuki-Miyaura cross coupling reaction For the 1-protected substrates CuCl 
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was added to enhance the rate of transmetallation and thus reduce protodeborylation of the -azinyl boronate.
13
 
However, for the 2-protected substrates, presumably reflecting the fact that these are not -azinyl boronates, this 
proved not to have any significant effect. Given that C-H borylation is an ideal strategy for late stage functionaliza-
tion we opted to use the indazole as the limiting reagent and adopted a standard reaction stoichiometry using one 
equivalent of aryl electrophile with respect to starting indazole. Under these conditions, the desired 3-
arylindazoles could be obtained in moderate to good overall yields (Table 2) from both N-1 and N-2 protected 
indazoles. Although cross-coupling of simple aryl chlorides proved not to be viable under these standard cross-
coupling conditions, a range of aryl and heteroaryl iodides and bromides, both electron rich and electron poor, 
proved to be effective partners. Importantly, the  
Table 2: Sequential one-pot Ir-catalyzed C-H borylation Suzuki-Miyaura cross-coupling reaction of N-protected 
indazoles 1 and 2
a 
   
tolerance of the Ir-catalyzed C-H borylation sequence enables an alternative approach to be employed and 
permits the easy generation of multi-substituted indazole cores to be established (Scheme 1). For example, 
borylation of 7-bromo-2-(2’-trimethsilylethoxymethyl) indazole 10a occurs selectively at the 3-position to afford 
boronate ester 11a. With this product it is possible to cross-couple the boronate ester selectively with aryl iodides 
and more reactive heteroaryl bromides while leaving the carbocyclic bromide available for subsequent transfor-
mations. Whilst initial attempts using Pd(dppf)Cl2 led to small but detectable amounts of homocoupling products, 
  
5 
using Pd(Ph3P)4 as the catalyst precursor led to exclusive formation of the desired 3-aryl-bromondazole 12 with 
no evidence for oligomerization of the bifunctional indazole being detected in the crude reaction mixture. A sub-
sequent second cross-coupling reaction then enables differentially 3,7-disubstituted indazoles to be accessed. 
Similar sequences are possible with the isomeric bromo-indazoles 10b-10d. As with other C-H borylation pro-
cesses, the regiochemistry of the borylation reaction is strongly influenced by steric parameters, and a bromine 
substituent at C-4 is sufficient to inhibit C-3 borylation and result in selective borylation at C-6. Sequential Suzuki-
Miyaura cross-coupling reactions, as described above, affords 4,6-disubstituted indazoles (14e). In an alternative 
second-stage of this sequence, reduction of the C-Br bond using ammonium formate affords the formal product of 
selective indazole C-6 borylation and cross-coupling (Scheme 2). Borylation of 2e and 10a with an excess of 
B2pin2 afforded the diborylated indazoles 16 and 17, respectively (Scheme 3).
14
 Disappointingly, attempts to 
achieve site selective Suzuki-Miyaura coupling reactions with these polyborylated products proved to be challeng-
ing, leading to complex  
Scheme 1. Multi-substituted indazoles through sequential borylation and cross-coupling 
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mixtures of mono and bis arylated products.
15
 However, exploiting the greater lability towards protodeborylation 
of the 3-boronate ester, simple treatment of the crude reaction mixture with aqueous KOH selectively afforded the 
C-5 borylated indazole 17.
16
 Without additional purification, this compound could be selectively cross-coupled 
with an aryl iodide providing entry to 5,7-disubstituted indazoles 19. 
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Scheme 2. Selective synthesis of C-6 substituted indazoles  
  
Scheme 3. Selective protodeborylation of poly borylated indazoles  
   
 
In summary, provided coordination of the azinyl nitrogen to the iridium catalyst is inhibited, the borylation of N-
protected indazoles proceeds readily to afford selectively the corresponding 3-boryl indazole. The presence of the 
second (azole) nitrogen reduces the basicity of the azinyl nitrogen atom facilitating the isolation of these boronate 
esters to the extent that when an electron withdrawing protecting group is employed the -azinyl boronate ester is 
stable to column chromatography. Moreover, in spite of the increased steric demand, but consistent with a lack of 
the inhibitory effect of an azinyl lone pair ortho to the site of C-H activation, borylation of N-2 protected indazoles 
occurs significantly faster than the equivalent N-1 protected analogue. The resulting borylated indazoles are via-
ble substrates for a variety of subsequent transformations providing easy routes for late stage modification of this 
  
8 
valuable heterocycle. In particular, the functional group tolerance of C-H borylation enables a halogen to serve as 
both a blocking and directing group providing access to regiocontrolled multi-substituted indazoles. 
 
Experimental Section 
 “One-pot” C-H borylation/Suzuki-Miyaura Cross-Coupling Sequence of protected 1H and 2H-indazoles In 
a glovebox, a thick-walled microwave synthesis vial was charged with the corresponding indazole (1 eq.) (vial A). 
A separate vial was charged with [Ir(COD)OMe]2 (1.5 mol%), dtbpy (3.0 mol%) and B2pin2 (0.7 eq.) before MTBE 
was added. Once homogenous, this solution was added to vial A. The vial was removed from the glovebox and 
heated at 80 °C for 1 h. Upon completion the volatiles were removed in vacuo to afford the crude boronate prod-
uct. Palladium catalyst 10 mol%, base (2 eq) and aryl halide (see schemes for details; 1.1 eq) were added and 
the vial was sealed and purged with 3 evacuation/refill (Ar) cycles. Solvent (DMF or DMAc) (5 mL) was added 
and the mixture was heated at 100 °C for 1 h in a microwave reactor. The reaction was diluted with water (10 mL) 
and extracted with Et2O (3 x 10 mL). The combined organic extracts were washed with brine (10 mL), dried over 
anhydrous MgSO4, filtered through celite and concentrated in vacuo to afford the crude product. Purification was 
achieved by flash column chromatography using the stated solvent system. 
Suzuki-Miyaura Cross-coupling of 3-Aryl-bromoindazoles A 5ml microwave vial was charged with bro-
moindazole (1 eq.), Pd(dppf)Cl2 (10mol%), Na2CO3 (3 equivalents) and aryl boronic acid (2 equivalents). The vial 
was evacuated and placed under N2 with three evacuation/refill cycles. 3.5 ml of degassed 6:1 dioxane/H2O was 
added. The mixture was heated to 105 
o
C for 2 hours. The reaction mixture was diluted with H2O (30 ml) and ex-
tracted with Et2O (3 x 20 ml). The combined organic layers were dried over MgSO4, filtered through celite and 
concentrated. The product was then purified by column chromatography. 
1-(Methanesulfonyl)-3-(Bpin)-1H-indazole (3g) In a glovebox, a thick-walled microwave synthesis vial was 
charged with the indazole (0.15 g, 0.8 mmol) (vial A). A separate vial was charged with [Ir(COD)OMe]2 (1.5 
mol%), dtbpy (3.0 mol%) and B2pin2 (0.7 eq.) before MTBE was added. Once homogenous, this solution was 
added to vial A. The vial was removed from the glovebox and heated at 80 °C for 1 h after which time the vola-
tiles were removed in vacuo and the crude boronate ester adsorbed onto silica.  Purification by flash column 
chromatography (0-5% MeOH in CHCl3) afforded 3g as an off-white solid. (0.154 g, 62%) H(400 MHz, CDCl3): 
8.13 (d, J = 8.0 Hz, 1H), 8.08 (d, J = 8.5 Hz, 1H), 7.53 (m, 1H), 7.38 (m, 1H), 3.33 (s, 3H), 1.42 (s, 12H); c (176 
MHz, CDCl3): 140.2, 130.5, 129.0, 124.3, 123.2, 112.8, 85.0, 41.5, 25.0; B (128 MHz, CDCl3): 28.9 (s (br)); 
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(ATR): νmax 1503, 1373, 1325, 1266, 1176, 1142, 1078, 956, 907 cm
-1
; Accurate Mass (ASAP): C14H19
10
BN2O4S 
requires M, 321.1195, found [M]
+
 321.1177. 
1-methyl-3-phenyl-1H-indazole (6ca) Isolated following purification by chromatography (5% EtOAc in Hexane) as 
a pale yellow oil (0.081 g, 43%). H (700 MHz, CDCl3): 8.03 (d, J = 8.0 Hz, 1H), 7.98 (d, J = 7.6 Hz, 2H), 7.51 (t, J 
= 7.6 Hz, 2H), 7.42 (m, 3H), 7.22 (ddd, J = 8.0, 5.4, 2.2 Hz, 1H), 4.14 (s, 3H); c(176 MHz, CDCl3): 143.9, 141.6, 
133.8, 128.9, 127.9, 127.5, 126.4, 121.8, 121.5, 121.0, 109.3, 35.7; m/z (GC/MS, EI): 208 [M]
+
, 180, 131 
[M−C6H5]
+
, 104, 77 [C6H5]
+
, 51. Accurate Mass (ASAP): C14H12N2 requires M, 208.1000, found [M]
+
 208.0995. 
1-(tetrahydro-2H-pyran-2”-yl)-3-(4'-(methoxycarbonyl)phenyl)-1H-indazole (6db) Isolated following purification by 
chromatography (0-25% EtOAc in hexane) as a white powder (0.168g, 50%). H (700 MHz) 8.16 (d, J = 8.4 Hz, 
2H), 8.08 (d, J = 8.4 Hz, 2H), 8.02 (d, J = 8.0 Hz,1H), 7.66 (d, J = 8.0 Hz, 1H), 7.44 (t, J = 8.0 Hz, 1H), 7.26 (t, J = 
8.0 Hz, 1H), 5.80 (dt, J = 9.1 Hz, 3.0 Hz, 1H), 4.07 (dt, J = 10.4 Hz, 3.5 Hz, 1H), 3.95 (s, 3H), 3.78 (td, J = 10.4 
Hz, 2.5 Hz, 1H), 2.67 (m, 1H), 2.20 (m, 1H), 2.12 (m, 1H), 1.79 (m, 2H), 1.68 (m, 1H). C (176 MHz) 170.0, 143.3, 
141.0, 138.2, 130.0, 129.3, 127.3, 126.6, 122.5, 122.0, 121.1, 110.7, 85.6, 67.6, 52.2, 29.3, 25.2, 22.5; max 
(ATR) 2940, 2843, 1716, 1609, 1432, 1279, 1075, 1038, 748, 696 cm
-1
; m/z (ASAP) 337.1 [MH]
+
, 305.1 [M-
OMe]
+
, 271.1, 253.1 [MH-THP]
+
; Accurate Mass (ASAP) C20H21N2O3 requires M, 337.1552, found [M+H]
+
 
337.1540.  
1'-tetrahydropyran-2’'-yl-3-(4-(trifluoromethyl)benzene)-1H-indazole (6dc) Isolated following purification by chro-
matography (0-3% Et2O in Hexane) as an off white solid (0.190 g, 42%). H (600 MHz, CDCl3): 8.11 (d, J = 8.2 
Hz, 2H), 7.99 (d, J = 8.0 Hz, 1H), 7.74 (d, J = 8.2 Hz, 2H), 7.67 (d, J = 8.0 Hz, 1H), 7.45 (t, J = 8.0 Hz, 1H), 7.28 
(t, J = 8.0 Hz, 1H), 5.81 (dd, J = 9.3, 2.7 Hz, 1H), 4.07 (m, 1H), 3.79 (m, 1H), 2.68 (m, 1H), 2.21 (m, 1H), 2.13 (m, 
1H), 1.79 (m, 2H), 1.69 (m, 1H); C (151 MHz, CDCl3): 143.2, 141.2, 137.4, 129.9 (q, J = 31.7 Hz), 127.9, 126.9, 
125.8 (q, J = 3.0 Hz), 124.3 (q, J = 273.3 Hz), 122.5, 122.3, 121.1, 110.8, 85.7, 67.7, 29.5, 25.3, 22.7; F (376 
MHz, CDCl3): −62.5; max  (ATR) 2948, 2866, 1615, 1332, 1066, 744 cm
-1
; m/z (GCMS, EI): 346 [MH
+
] 10%, 262 
[M-THP]
+
 100%; Accurate Mass (ASAP) C19H18F3N2O requires M, 347.1371, found [M+H]
+
 347.1363. 
3-(4'-methoxyphenyl)-1-(tetrahydro-2H-pyran-2”-yl)-1H-indazole (6dd) Isolated following purification by chroma-
tography (0-40% Et2O in hexane) as a white powder (0.127g, 42%). H (700 MHz, CDCl3) 7.96 (d, J = 8.1 Hz, 
1H), 7.91 (d, J = 8.7 Hz, 2H), 7.61 (d, J = 8.1 Hz, 1H), 7.40 (t, J= 8.1 Hz, 1H), 7.21 (t, J = 8.1 Hz, 1H), 7.03 (d, J = 
8.7 Hz, 2H), 5.76 (dd, J = 9.4 Hz, 2.8 Hz, 1H), 4.07 (d, J = 11.1 Hz, 1H), 3.87 (s, 3H), 3.76 (td, J = 11.1 Hz, 2.6 
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Hz, 1H), 2.67 (m, 1H), 2.19 (m, 1H), 2.10 (m, 1H), 1.78 (m, 2H), 1.66 (m, 1H) C (176 MHz, CDCl3) 159.5, 144.4, 
140.9, 128.9, 126.5, 126.4, 122.6, 121.4, 120.1, 114.1, 110.3, 85.5, 67.5, 55.3, 29.5, 25.1, 22.7; max  (ATR) 
2939, 2849, 1611, 1529, 1078, 1037, 833, 742 cm
-1
; m/z (ASAP) 309.2 [MH]
+
, 225.1 [MH-THP]
+
; Accurate mass 
(ASAP) C19H21N2O2 requires M, 309.1603, found [M+H]
+
 309.1597. 
1-Tetrahydropyran-2’-yl-3-pyridin-2’’-yl-1H-indazole (6de) Isolated following purification by chromatography (0-
10% EtOAc in Hexane) as a colourless oil (0.15 g, 48%) H (700 MHz, CDCl3): 8.74 (d, J = 4.7 Hz, 1H), 8.67 (d, J 
= 8 Hz, 1H), 8.23 (d, J = 7.9 Hz, 1H), 7.76 (m, 1H), 7.62 (d, J = 8 Hz, 1H), 7.43 (t, J = 8 Hz, 1H), 7.29 (t , J = 8 Hz, 
1H), 7.24 (m, 1H), 5.81 (dd, J = 9.2, 2.7 Hz, 1H), 4.07 (m, 1H), 3.78 (m, 1H), 2.68 (m, 1H), 2.21 (m, 1H), 2.12 (m, 
1H), 1.79 (m, 2H), 1.69 (m, 1H); C (176 MHz, CDCl3): 153.7, 149.3, 143.6, 141.2, 136.4, 126.8, 123.9, 123.2, 
122.4, 122.3, 121.4, 110.1, 85.7, 67.6, 29.5, 25.3, 22.7; max (ATR) 2942, 1592, 1562, 1510, 1490, 1459, 1442, 
1378, 1315, 1279, 1235, 1206, 1172, 1148, 1112, 1080, 1040, 1003, 906, 876, 795 cm
-1
; Accurate Mass (ASAP) 
C17H18N3O requires M, 280.1450, [M+H]
+
 found 280.1441. 
3-(Thiophen-3'-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-indazole (6ef) Isolated following purification by chroma-
tography (0-40% Et2O in hexane) as a yellow oil (0.106g, 32%). H (700MHz, CDCl3) 7.99 (d, J = 8.2 Hz, 1H), 
7.82 (m, 1H), 7.72 (d, J = 5.4 Hz, 1H), 7.60 (d, J = 8.2 Hz, 1H) 7.46 (m, 1H, 5’-H), 7.45 (m, 1H), 7.27 (t, J = 8.2 
Hz, 1H), 5.77 (s, 2H), 3.61 (t, J =8.1 Hz, 2H), 0.91 (t, J =8.1 Hz, 2H), -0.06 (s, 9H)C (176 MHz, CDCl3) 141.3, 
141.2, 134.6, 127.1, 126.9, 126.1, 122.7, 122.3, 121.8, 121.3, 110.1, 77.8, 66.6, 17.9, -1.3; max  (ATR) 2949, 
2893, 1614, 1075, 856, 832, 741, 674 cm
-1
; m/z (GCMS, EI) 330 [M]
+
 60%, 257 [M-(CH3)3Si]
+
 50%, 214 [MH-
(CH3)3SiCH2CH2O]
+
 100%, 128 [MH-SEM]
+
 20%, 73 [(CH3)3Si]
+
 35%; Accurate Mass (ASAP) C17H23N2OSSi re-
quires M, 331.1300, found [M+H]
+
 331.1302. 
2-methyl-3-phenyl-2H-indazole (7ca). Isolated following purification by chromatography (0-10% Et2O in Hexane) 
as a pale yellow oil (0.064 g, 44%). H (700 MHz, CDCl3): 7.71 (d, J = 8.7 Hz, 1H), 7.59 (d, J = 8.4 Hz, 1H), 7.55 
(m, 4H), 7.50 (m, 1H), 7.32 (m, 1H), 7.08 (m, 1H), 4.19 (s, 3H); C (176 MHz, CDCl3): 148.3, 136.2, 129.9, 129.8, 
129.2, 128.9, 126.4, 122.0, 121.4, 120.3, 117.2, 38.7; m/z (GC/MS, EI): 208 [M]
+
, 180, 165, 104, 77 [C6H5]
+
. max 
(ATR) 2363, 1500, 1361, 1287, 1009, 904 cm
-1
; Accurate Mass (ASAP) C14H13N2 requires M, 209.1077, found 
[M+H]
+
 209.1079. 
2-((2-(trimethylsilyl)ethoxy)methyl)-3-(4-(methoxycarbonyl)phenyl)-2H-indazole (7eb) Isolated following purifica-
tion by chromatography (0-10% EtOAc in Hexane) as a colorless oil (0.21 g, 51%). H (700 MHz, CDCl3): 8.22 (m, 
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2H), 7.86 (m, 2H), 7.77 (d, J = 8.7 Hz, 1H), 7.68 (d, J = 8.5 Hz, 1H), 7.36 (m, 1H), 7.15 (m, 1H), 5.71 (s, 2H), 3.97 
(s, 3H), 3.87 (t, J = 8.3 Hz, 2H), 0.97 (t, J = 8.3 Hz, 2H), −0.01 (s, 9H); C (176 MHz, CDCl3): 166.7, 148.3, 135.7, 
134.0, 130.3, 130.2, 129.8, 127.1, 123.1, 121.5, 120.5, 118.2, 79.6, 67.9, 52.5, 18.1, −1.3; max (ATR) 2952, 
1717, 1612, 1490, 1436, 1276, 1249, 1228, 1175, 1149, 1080, 1018, 906, 860, 835, 782 cm
-1
; Accurate Mass 
(ASAP) C21H27N2O3Si requires M, 383.1791, found [M+H]
+
 383.1803. 
2-((2-(trimethylsilyl)ethoxy)methyl)-3-pyridin-2’-yl-2H-indazole (7ee) Isolated following purification by chromatog-
raphy (20% Et2O in Hexanes) as a colourless oil (0.16 g, 47%). H (700 MHz, CDCl3): 8.80 (m, 1H), 7.88 (m, 3H), 
7.79 (d, J = 8.7 Hz, 1H), 7.34 (m, 2H), 7.18 (m, 1H), 6.15 (s, 2H), 3.68 (t, J = 8.3 Hz, 2H), 0.86 (t, J = 8.3 Hz, 2H), 
−0.10 (s, 9H); C (176 MHz, CDCl3): 150.3, 149.5, 148.3, 137.0, 134.4, 126.8, 124.4, 123.4, 122.7, 121.7, 120.8, 
118.4, 80.3, 67.4, 18.0, −1.4; max (ATR) 2953, 1586, 1490, 1459, 1364, 1306, 1249, 1152, 1088, 1021, 906, 859, 
835, 786 cm
-1
; Accurate Mass (ASAP) C18H24N3OSi requires M, 326.1689, found [M+H]
+
 326.1692. 
2-((2-(Trimethylsilyl)ethoxy)methyl)3-thiophen-3’-yl-2H-indazole (7ef) Isolated following purification by chromatog-
raphy (0-5% EtOAc in Hexane) as a pale yellow oil(0.13 g, 41%). H (700 MHz, CDCl3): 7.85 (m, 1H), 7.73 (m, 
2H), 7.58 (m, 1H), 7.52 (m, 1H), 7.33 (m, 1H), 7.12 (m, 1H), 5.73 (s, 2H), 3.82 (t, J = 8.3 Hz, 2H), 0.96 (t, J = 8.3 
Hz, 2H), −0.02 (m, 9H); C (176 MHz, CDCl3): 148.1, 132.4, 129.8, 128.3, 127.0, 126.7, 125.8, 122.4, 121.2, 
120.9, 118.0, 79.6, 67.6, 18.2, −1.3; max (ATR) 2953, 2224, 1627, 1478, 1408, 1293, 1267, 1249, 1080, 1021, 
907, 856, 834, 790 cm
-1
; Accurate Mass (ASAP)  C17H23N2OSSi requires M, 331.1300, found [M+H]
+
 331.1266. 
2-((2-(trimethylsilyl)ethoxy)methyl)-3-(4'-(methoxycarbonyl)phenyl)-7-bromo-2H-indazole (12a) 
Isolated following purification by chromatography (0-30% Et2O in hexane) as a white powder (0.198g, 43%). H 
(700 MHz, CDCl3) 8.22 (d, J = 8.3 Hz, 2H), 7.83 (d, J = 8.3 Hz, 2H), 7.62 (d, J = 8.4 Hz, 1H), 7.57 (d, J = 7.3 Hz, 
1H), 7.00 (dd, J = 8.4 Hz, 7.3 Hz, 1H), 5.74 (s, 2H), 3.97 (s, 3H), 3.88 (t, J = 8.3 Hz, 2H), 0.95 (t, J = 8.3 Hz, 2H), 
-0.01 (s, 9H), C (176MHz, CDCl3) 166.5, 146.8, 137.1, 133.5, 130.5, 130.2, 129.7, 129.6, 123.5, 122.2, 119.9, 
111.7, 79.5, 67.7, 52.4, 17.9, -1.4; max (ATR) 2942, 2894, 1649, 1576, 1278, 1228, 1202, 1082, 1038, 744, 684 
cm
-1
; m/z (ASAP) 463.1 [M(
81
Br)H]
+
, 461.1 [M(
79
Br)H]
+
, 403.0 [M(
81
Br)-CO2Me]
+
, 401.0 [M(
79
Br)-CO2Me]
+
; Accu-
rate Mass (ASAP) C21H26N2O3Si
79
Br requires M, 461.0896, found [M+H]
+
 461.0911. 
2-(2-(Trimethylsilyl)ethoxymethyl)-3-(4'-methoxycarbonyl)-7-(furan-3”-yl)-2H-indazole (14a) Isolated following 
purification by chromatography (0-20% Et2O in hexane) as a yellow oil (0.127g, 63%) H (700 MHz, CDCl3) 8.64 
(dd, J = 1.5 Hz, 0.6 Hz, 1H), 8.22 (d, J = 8.6 Hz, 2H), 7.86 (d, J = 8.6 Hz, 2H), 7.57 (dd, J = 8.5 Hz, 0.8 Hz, 1H), 
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7.53 (t, J = 1.5 Hz, 1H), 7.51 (dd, J = 6.9 Hz, 0.8 Hz, 1H), 7.18 (dd, J = 8.5 Hz, 6.9 Hz, 1H), 7.01 (dd, J = 1.5 Hz, 
0.6 Hz, 1H), 5.74 (s, 2H), 3.97 (s, 3H), 3.94 (t, J = 8.3 Hz, 2H), 1.00 (t, J = 8.3 Hz, 2H), 0.00 (s, 9H), C (176 MHz, 
CDCl3) 166.6, 145.9, 142.8, 142.5, 135.7, 134.0, 130.2, 130.1, 129.7, 123.2, 123.0, 122.5, 122.2, 121.9, 118.8, 
108.4, 79.4, 67.8, 52.3, 18.0, -1.3; max  (ATR) 1721, 1610, 1435, 1202, 1085, 1001, 835, 751 cm
-1
; m/z (ASAP) 
449.2 [MH]
+
, 421.1 [MH-OMe]
+
, 391.1 [MH-CO2Me]
+
, 331.1 [MH-(Me3Si(CH2)2O)]
+
; Accurate Mass (ASAP) 
C25H28N2O4Si requires M, 448.1818, found [M]
+
 448.1808. 
6-Bromo-2-((2-(trimethylsilyl)ethoxy)methyl)-3-pyridin-2’-yl-2H-indazole (12b) Isolated following purification by 
chromatography (15% EtOAc in Hexanes) as a pale yellow oil(179 mg, 52%). H (700 MHz, CDCl3): 8.80 (d, J = 
5.4 Hz, 1H), 7.95 (s, 1H), 7.87 (m, 2H), 7.79 (d, J = 8.9 Hz, 1H), 7.35 (t, J = 5.4 Hz, 1H), 7.24 (d, J = 8.9 Hz, 1H), 
6.08 (s, 2H) 3.68 (t, J = 8.3 Hz, 2H), 0.87 (t, J = 8.3 Hz, 2H), −0.09 (s, 9H); C (176 MHz, CDCl3): 150.4, 148.9, 
148.8, 137.2, 135.1, 127.1, 124.4, 123.1, 122.5, 120.9, 120.7, 120.3, 80.3, 67.6, 18.0, −1.3; max (ATR) 2951, 
1584, 1470, 1244, 1092, 1014, 908, 832; Accurate Mass (ASAP) C18H23
79
BrN3OSi requires M, 404.0789, found 
[M+H]
+
 404.0794. 
2-((2-(trimethylsilyl)ethoxy)methyl)-3-pyridin-2’-yl-6-(4’’-(methoxycarbonyl)phenyl)-2H-indazole (14b)  
Isolated following purification by chromatography (0-20% EtOAc in Hexanes) to give 14b (137 mg, 76%), as an 
off-white solid. H (700 MHz, CDCl3): 8.82 (d, J = 4.5 Hz, 1H), 8.14 (d, J = 8.3 Hz, 2H), 8.02 (s, 1H), 7.99 (d, J = 
8.3 Hz, 1H), 7.91 (m, 2H), 7.77 (d, J = 8.3 Hz, 2H), 7.47 (d, J = 8.3 Hz, 1H), 7.35 (ddd, J = 6.6, 4.5, 1.4 Hz, 1H), 
6.16 (s, 2H), 3.95 (s, 3H), 3.71 (t, J = 8.3 Hz, 2H), 0.88 (t, J = 8.3 Hz, 2H), −0.09 (s, 9H); C (176 MHz, CDCl3): 
167.1, 150.4, 149.3, 148.6, 146.1, 138.7, 137.1, 134.6, 130.3, 129.1, 127.4, 124.4, 123.6, 122.9, 121.6, 121.4, 
116.7, 80.4, 67.5, 52.3, 18.0, −1.3; max (ATR) 2949, 1719, 1607, 1536, 1478, 1280, 1102 cm
-1
; Accurate Mass 
(ASAP) C26H30N3O3Si requires 460.2056, found [M+H]
+
 460.2046. 
2-(2-(trimethylsilyl)ethoxymethyl)-3-(4'-methoxycarbonylphenyl)-5-bromo-2H-indazole (12c) Isolated following 
purification by chromatography (0-30% Et2O in hexane) as a yellow oil (0.198g, 43%). H (700 MHz, CDCl3) 8.23 
(d, J = 8.2 Hz, 2H), 7.86 (d, J = 8.2 Hz, 2H), 7.76 (d, J = 9.0 Hz, 1H), 7.70 (s, 1H), 7.51 (d, J = 9.0 Hz, 1H), 5.68 
(s, 2H), 3.97 (s, 3H), 3.84 (t, J = 8.4 Hz, 2H), 0.95 (t, J = 8.4 Hz, 2H), 0.02 (s, 9H), C (176 MHz, CDCl3) 166.5, 
135.7, 133.8, 130.2, 130.1, 129.6, 127.3, 126.7, 126.6, 121.7, 118.6, 116.0, 79.5, 67.6, 52.2, 18.0, -1.4; max 
(ATR) 2953, 1764, 1610, 1436, 1201, 1093, 860, 836, 706 cm
-1
; m/z (ASAP) 463.1 [M(
81
Br)H]
+
, 461.1 [M(
79
Br)H]
+
, 
433.1 [MH-OMe]
+
, 403.0 [MH-CO2Me]
+
, 376.0 [MH-(Me3SiCH2)]
+
; Accurate Mass (ASAP) C21H26BrN2O3Si 
requires M, 461.0896, found [M+H]
+ 
461.0898. 
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2-(2-(Trimethylsilyl)ethoxymethyl)-3-(4'-methoxycarbonylphenyl)-5-(furan-3”-yl)-2H-indazole (14c) Isolated 
following purification by chromatography (0-25% Et2O in hexane) as a yellow oil (64mg, 72%).  
H (700 MHz, CDCl3) 8.23 (d, J = 8.4 Hz, 2H), 7.86 (d, J = 8.4 Hz, 2H), 7.76 (dd, J = 9.0 Hz, 1.2 Hz, 1H), 7.74 (t, J 
= 1.3 Hz, 1H), 7.70 (t, J = 1.2 Hz, 1H)), 7.51 (dd, J = 9.0Hz, 1.2 Hz, 1H), 7.47 (t, J = 1.3 Hz, 1H), 6.71 (m, 1H), 
5.68 (s, 2H), 3.97 (s, 3H), 3.85 (t, J = 8.3 Hz, 2H), 0.96 (t, J = 8.3 Hz, 2H), -0.02 (s, 9H), C (176 MHz, CDCl3) 
166.6, 147.6, 143.7, 138.4, 135.7, 133.9, 130.2, 130.1, 129.6, 127.3, 126.8, 126.6, 121.7, 118.6, 116.1, 108.8, 
79.5, 67.8, 52.3, 17.9, -1.3; max (ATR) 2953, 2918, 1764, 1610, 1457, 1200, 1089, 861, 835 cm
-1
; m/z (ASAP) 
449.2 [MH]
+
, 391.1 [MH-CO2Me]
+
, 331.1 [M-(Me3Si(CH2)2O)]
+
, 287.1 [M-(Me3Si(CH2)OCH2)]
+
; Accurate Mass 
(ASAP) C25H29N2O4Si requires M, 449.1897, found [M+H]
+
 449.1889.  
2-(Trimethylsilylethoxymethyl)-3-(pyrid-2'-yl)-5-bromoindazole (12d) Isolated following purification by chromatog-
raphy (0-50% Et2O in hexane) as a yellow oil (0.141g, 35%). H (700 MHz, CDCl3) 8.80 (m, 1H, 6'-H), 8.08 (dd, J 
= 1.8Hz, 0.8 Hz, 1H), 7.88 (m, 1H), 7.86 (m, 1H), 7.65 (dd, J = 9.2 Hz, 0.8 Hz, 1H), 7.39 (dd, J = 9.2 Hz, 1.8 Hz, 
1H), 7.34 (m, 1H), 6.08 (s, 2H), 3.67 (t, J = 8.3 Hz, 2H), 0.86 (t, J = 8.3 Hz, 2H), -0.10 (s, 9H)) C (176 MHz, 
CDCl3) 1 50.2, 148.7, 146.4, 137.0, 133.9, 130.3, 124.2, 123.1, 122.9, 122.7, 119.9, 116.9, 80.2, 67.3, 17.7, -1.6; 
max (ATR) 2969, 1365, 1217, 908, 725 cm
-1
;
 
m/z (ASAP) 406.1 [M(
81
Br)H]
+
, 404.1 [M(
79
Br)H]
+
, 287.0 [M+H-
(Me3Si(CH2)2O)]
+
; Accurate Mass (ASAP) C18H23BrN3OSi requires M, 404.0794, found [M+H]
+
 404.0782. 
2-(2-Trimethylsilyl)ethoxymethyl)-3-(pyrid-2'-yl)-5-(4”-(trifluoromethyl)phenyl)-2H-indazole (14d) Isolated following 
purification by chromatography (0-50% Et2O in hexane) as a yellow oil (80mg, 68%). H  (700 MHz, CDCl3) 8.82 
(m, 1H, 6'-H), 8.10 (dd, J = 1.7 Hz, 0.8 Hz, 1H), 7.92 (dt, J = 7.8 Hz, 1.2 Hz, 1H), 7.89 (td, J = 7.8 Hz, 1.8 Hz, 1H), 
7.87 (dd, J =9.0 Hz, 0.8 Hz, 1H), 7.74 (d, J = 8.3 Hz, 2H), 7.68 (d, J = 8.3 Hz, 2H), 7.60 (dd, J = 9.0 Hz, 1.7 Hz, 
1H), 7.35 (m, 1H), 6.12 (s, 2H), 3.72 (t, J = 8.2 Hz, 2H), 0.88 (t, J = 8.2 Hz, 2H), -0.09 (s, 9H), C (176 MHz, 
CDCl3) 150.3, 149.0, 147.8, 145.2, 137.0, 135.2, 135.0, 129.0 (q, J = 32.5 Hz), 127.5, 126.9, 125.6 (q, J = 3.8 
Hz), 124.5 (q, J = 272.5 Hz), 124.3, 122.8, 121.9, 119.5, 118.9, 80.3, 67.6, 17.8, -1.4; max  (ATR) 1615, 1587, 
1325, 1198, 1122, 1091, 839 cm
-1
; m/z (ASAP) 470.2 [M+H]
+
, 353.1 [M-(Me3Si(CH2)2O)]
+
, 335.1 [M-
(Me3Si(CH2)2OCH2)]
+
; Accurate Mass (ASAP) C25H27F3N3OSi requires M, 470.1875, found [M+H]
+ 
470.1873. 
4-Bromo-2-((2-(trimethylsilyl)ethoxy)methyl)-6-(4-(methoxycarbonyl)phenyl)-2H-indazole (12e) 
Isolated following purification by chromatography (0-25% Et2O in Hexane) as an off white solid (267 mg, 61%). 
12e H (700 MHz, CDCl3): 8.16 (s(br), 1H), 8.13 (m, 2H), 7.89, (s(distorted), 1H), 7.71 (m, 2H), 7.57 (d, J = 1.1 
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Hz, 1H), 5.74 (s, 2H), 3.95 (s, 3H), 3.67, (t, J = 8.3 Hz, 2H), 0.97 (t, J = 8.3 Hz, 2H), −0.01 (s, 9H); C (176 MHz, 
CDCl3): 167.0, 149.1, 144.9, 139.6, 130.4, 129.5, 127.4, 125.1, 124.1, 124.0, 115.7, 114.2, 82.3, 68.0, 52.3, 18.0, 
−1.3;  max (ATR) 2953, 1723, 1610, 1555, 1436, 1369, 1285, 1250, 1197, 1104, 1079, 1018, 930, 836, 795, 772 
cm
-1
; Accurate Mass (ASAP) C21H26
79
BrN2O3Si requires M, 461.0896, found [M+H]
+
 461.0893. 
2-((2-(Trimethylsilyl)ethoxy)methyl)-4-(4’-methylphenyl)-6-(4’’-(methoxycarbonyl)phenyl)-2H-indazole (14e) Isolat-
ed following purification by chromatography (0-10% ethyl acetate in hexane) as a colorless oil (85 mg, 72%). H 
(700 MHz, CDCl3): 8.27 (s, 1H), 8.14 (d, J = 8.3 Hz, 2H), 7.93 (s, 1H), 7.79 (d, J = 8.3 Hz, 2H), 7.64 (d, J = 8.0 
Hz, 2H), 7.45 (s, 1H), 7.33 (d, J = 8.0 Hz, 2H), 5.75 (s, 2H), 3.95 (s, 3H), 3.67 (t, J = 8.3 Hz, 2H), 2.45 (s, 3H) 
0.96 (t, J = 8.3 Hz, 2H), −0.02 (s, 9H); C (176 MHz, CDCl3): 167.2, 150.0, 146.3, 138.9, 138.0, 137.3, 135.6, 
130.3, 129.8, 129.1, 128.1, 127.5, 123.2, 121.6, 121.2, 115.3, 82.2, 67.8, 52.3, 21.4, 18.0, −1.3; max (ATR) 2949, 
1719, 1612, 1511, 1435, 1278, 1102, 912 cm
-1
; Accurate Mass (ASAP) C28H33N2O3Si requires M 473.2260, found 
[M+H]
+
 473.2249. 
2-((2-(Trimethylsilyl)ethoxy)methyl)-6-(4-(methoxycarbonyl)phenyl)-2H-indazole (15). 12e (130 mg, 0.28 mmol), 
was dissolved in ethanol (10 mL) and ammonium formate (353 mg, 5.6 mmol, 20 eq.) was charged. The reaction 
vessel was evacuated and backfilled with nitrogen (x 3 cycles) before 10% Pd/C (15 mg, 0.014 mmol, 5 mol%) 
was slowly added under a positive pressure of nitrogen. The reaction was stirred at room temperature for 2 h then 
filtered through a plug of celite and dry-loaded onto silica for purification by flash column chromatography (15% 
ethyl acetate in hexane) giving 15 as a viscous clear oil (94 mg, 88%). H (700 MHz, CDCl3): 8.13 (m, 2H), 7.97 
(s, 1H), 7.78 (d, J = 8.7 Hz, 1H), 7.74 (m, 2H), 7.40 (dd, J = 8.7, 1.4 Hz, 1H), 5.75 (s, 2H), 3.95 (s, 3H), 3.66 (t, J 
= 8.3 Hz, 2H), 0.96 (t, J = 8.3 Hz, 2H), −0.02 (s, 9H); C (176 MHz, CDCl3): 167.2, 149.3, 146.2, 138.4, 130.3, 
129.0, 127.4, 122.9, 122.6, 122.0, 121.3, 116.5, 82.1, 67.8, 52.3, 18.0, −1.3; max (ATR) 2954, 1720, 1607, 1435, 
1281, 1108, 932 cm
-1
; Accurate Mass (ASAP) C21H27N2O3Si requires M, 383.1791, found [M+H]
+
 383.1787. 
2-(2-(Trimethylsilyl)ethoxymethyl)-5-(4'-methoxyphenyl)-7-bromo-2H-indazole (19). In a glovebox, a thick-walled 
microwave synthesis vial was charged with 10a (327mg, 1 mmol) (vial A). A separate vial was charged with 
[Ir(COD)OMe]2 (5 mol%), dtbpy (10 mol%) and B2pin2 (2 eq.) before MTBE (2.5ml) was added. Once homogene-
ous, this solution was added to vial A. The vial was removed from the glovebox and heated at 80 °C for 2 h. Upon 
completion the volatiles were removed in vacuo to afford the crude boronate product. KOH (3 eq) was added and 
the vial was sealed and purged with 3 evacuation/refill (Ar) cycles. DMA (5 mL) and H2O (0.5 mL) were added 
and the mixture was heated to 70 °C for 15 minutes. The mixture was added to a vial containing Pd(PPh3)4 (10 
  
15 
mol%), K3PO4 (2 eq.) and 4-iodoanisole (1.1 eq.), which had been purged with 3 evacuation/refill (Ar) cycles, and 
heated for a further 2h at 70
o
C. The reaction was diluted with water (30 mL) and extracted with Et2O (4 x 20 mL). 
The combined organic extracts were washed with brine (10 mL), dried over anhydrous MgSO4, filtered through 
celite and concentrated in vacuo to afford the crude product. Purification by flash column chromatography (0-40% 
Et2O in hexane) afforded 19 as a white powder (0.199g, 46%) H (700 MHz, CDCl3) 8.23 (s, 1H), 7.78 (s, 1H), 
7.74 (s, 1H), 7.52 (d, J = 8.7 Hz, 2H), 6.98 (d, J = 8.7 Hz, 2H), 5.77 (s, 2H), 3.85 (s, 3H), 3.66 (t, J = 8.5 Hz, 2H), 
0.95 (t, J = 8.5 Hz, 2H), -0.02 (s, 9H); C (176 MHz, CDCl3) 159.1, 146.6, 136.1, 133.0, 129.8, 128.2, 124.0, 
123.4, 116.8, 114.4, 111.7, 82.3, 67.8, 55.4, 17.9, -1.33; max (ATR) 2190, 1981, 1502, 1246, 1096, 832, 743; m/z 
(ASAP) 434.1 [(
81
Br)M]
+
, 432.1 [(
79
Br)M]
+
, 350.0 [(
81
Br)M-(Me3SiCH2)]
+
, 348.0 [(
79
Br)M-(Me3SiCH2)]
+
; Accurate 
Mass (ASAP) C20H25
79
BrN2O2Si requires M, 432.0869, found m/z [M]
+
 432.0865.  
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